These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1322 related items for PubMed ID: 17760715

  • 21. Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
    Madisch A, Miehlke S, Neuber F, Morgner A, Kuhlisch E, Rappel S, Lehn N, Bayerdörffer E, Seitz G, Stolte M.
    Aliment Pharmacol Ther; 2006 Feb 15; 23(4):473-9. PubMed ID: 16441467
    [Abstract] [Full Text] [Related]

  • 22. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M, Catalán M, Gisbert JP, Calvet X.
    Aliment Pharmacol Ther; 2005 Jun 15; 21(12):1411-8. PubMed ID: 15948807
    [Abstract] [Full Text] [Related]

  • 23. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE, Dickson A, El-Nujumi A, El-Omar E, Kelman A.
    Am J Gastroenterol; 2000 Jan 15; 95(1):101-5. PubMed ID: 10638566
    [Abstract] [Full Text] [Related]

  • 24. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A, Remacha B, Sáinz R, Hirschowitz BI.
    Am J Gastroenterol; 2000 Feb 15; 95(2):513-9. PubMed ID: 10685760
    [Abstract] [Full Text] [Related]

  • 25. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI.
    Ital J Gastroenterol Hepatol; 1997 Oct 15; 29(5):465-9. PubMed ID: 9494858
    [Abstract] [Full Text] [Related]

  • 26. Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
    Schaeverbeke T, Broutet N, Zerbib F, Combe B, Bertin P, Lamouliatte H, Perié F, Joubert-Collin M, Mégraud F.
    Am J Gastroenterol; 2005 Dec 15; 100(12):2637-43. PubMed ID: 16393213
    [Abstract] [Full Text] [Related]

  • 27. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T, Kanoh Y, Higuchi K, Arakawa T, Morisita T.
    Hepatogastroenterology; 2003 Dec 15; 50(51):607-9. PubMed ID: 12828043
    [Abstract] [Full Text] [Related]

  • 28. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
    Mak SK, Loo CK, Wong PN, Lo KY, Tong GM, Lam EK, Wong AK.
    Singapore Med J; 2003 Feb 15; 44(2):74-8. PubMed ID: 14503780
    [Abstract] [Full Text] [Related]

  • 29. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
    Katsinelos P, Tziomalos K, Chatzimavroudis G, Vasiliadis T, Katsinelos T, Pilpilidis I, Triantafillidis I, Paroutoglou G, Papaziogas B.
    Med Princ Pract; 2007 Feb 15; 16(2):119-23. PubMed ID: 17303947
    [Abstract] [Full Text] [Related]

  • 30. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers.
    Venerito M, Malfertheiner P.
    Helicobacter; 2010 Aug 15; 15(4):239-50. PubMed ID: 20633184
    [Abstract] [Full Text] [Related]

  • 31. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B, Kavcic B, Gubina M, Krizman I.
    Hepatogastroenterology; 1999 Aug 15; 46(27):1746-50. PubMed ID: 10430336
    [Abstract] [Full Text] [Related]

  • 32. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Tang CL, Ye F, Liu W, Pan XL, Qian J, Zhang GX.
    Helicobacter; 2012 Aug 15; 17(4):286-96. PubMed ID: 22759329
    [Abstract] [Full Text] [Related]

  • 33. The effect of antibiotic therapy on bleeding from duodenal ulcer.
    Sonnenberg A, Olson CA, Zhang J.
    Am J Gastroenterol; 1999 Apr 15; 94(4):950-4. PubMed ID: 10201462
    [Abstract] [Full Text] [Related]

  • 34. Dual versus triple therapy in eradication of Helicobacter pylori.
    Ohlin B, Cederberg A, Kjellin T, Kullman E, Melén K, von Holstein CS, Thoring M.
    Hepatogastroenterology; 2002 Apr 15; 49(43):172-5. PubMed ID: 11941946
    [Abstract] [Full Text] [Related]

  • 35. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J, Börsch G.
    Am J Gastroenterol; 1994 Oct 15; 89(10):1785-8. PubMed ID: 7942667
    [Abstract] [Full Text] [Related]

  • 36. Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.
    Kikuchi S, Kato M, Katsuyama T, Tominaga S, Asaka M.
    Helicobacter; 2006 Jun 15; 11(3):147-51. PubMed ID: 16684261
    [Abstract] [Full Text] [Related]

  • 37. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.
    Am J Gastroenterol; 2002 Sep 15; 97(9):2208-14. PubMed ID: 12358234
    [Abstract] [Full Text] [Related]

  • 38. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.
    Bytzer P, Teglbjaerg PS, Danish Ulcer Study Group.
    Am J Gastroenterol; 2001 May 15; 96(5):1409-16. PubMed ID: 11374675
    [Abstract] [Full Text] [Related]

  • 39. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study.
    Fujioka T, Uribe RU, Kubota T, Murakami K, Kawasaki H, Nasu M.
    Eur J Gastroenterol Hepatol; 1995 Aug 15; 7 Suppl 1():S35-8. PubMed ID: 8574733
    [Abstract] [Full Text] [Related]

  • 40. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
    Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VK, Wu JC, Lau JY, Hui Y, Lai MS, Chan HL, Sung JJ.
    N Engl J Med; 2001 Mar 29; 344(13):967-73. PubMed ID: 11274623
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 67.